Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with <sup>10</sup>B-Borocaptate Sodium (BSH) and <sup>10</sup>B-Paraboronophenylalanine (BPA)
Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy that utilizes the cancer targeting <sup>10</sup>B-compound. Cancer cells that take up the compound are substantially damaged by the high liner energy transfer (LET) particles emitted mainly from the <sup>10<...
Saved in:
Main Author: | Hiroshi Fukuda |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/242afb52f4eb4a05a5e7dd73eca2140d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using <sup>10</sup>B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
by: Hiroshi Fukuda
Published: (2021) -
Polymer-Coated Nanoparticles for Therapeutic and Diagnostic Non-<sup>10</sup>B Enriched Polymer-Coated Boron Carbon Oxynitride (BCNO) Nanoparticles as Potent BNCT Drug
by: Chen-Wei Chiang, et al.
Published: (2021) -
Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy
by: Chen J, et al.
Published: (2019) -
Comparison of Conventional and Radiomic Features between <sup>18</sup>F-FBPA PET/CT and PET/MR
by: Chien-Yi Liao, et al.
Published: (2021) -
Phenotype remodeling in neutrophilic granulocyte subsets CD64<sup>-</sup>CD32<sup>+</sup>CD16<sup>+</sup>CD11B<sup>+</sup>NG, CD64<sup>+</sup>CD32<sup>+</sup>CD16<sup>+</sup>CD11B<sup>+</sup>NG in <i>de novo</i> experimental model of viral-bacterial infection <i>in vitro</i>
by: I. V. Nesterova, et al.
Published: (2021)